Salvia divinorum

Salvia, salvinorins & derivatives



Jump to:



Page 3

Kelly (2011). Legally tripping: a qualitative profile of Salvia divinorum use among young adults. Journal of Psychoactive Drugs.

Listos, Merska & Fidecka (2011). Pharmacological activity of salvinorin A, the major component of Salvia divinorum. Pharmacological Reports.

Mendelson et al. (2011). Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial. Psychopharmacology.

Peet & Baker (2011). Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A. Behavioural Pharmacology.

Wu et al. (2011). Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Substance Abuse and Rehabilitation.

Schmidt et al. (2011). "Legal highs" on the net-Evaluation of UK-based Websites, products and product information. Forensic Science International.

Sumnall et al. (2011). Salvia divinorum use and phenomenology: results from an online survey. Journal of Psychopharmacology.

Vohra et al. (2011). Salvia divinorum: exposures reported to a statewide poison control system over 10 years. The Journal of Emergency Medicine.

Addy (2012). Acute and post-acute behavioral and psychological effects of salvinorin A in humans. Psychopharmacology.

Barnes & Snow (2012). Analysis of Salvinorin A in plants, water, and urine using solid-phase microextraction-comprehensive two-dimensional gas chromatography-time of flight mass spectrometry. Journal of Chromatography.

Butelman et al. (2012). Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo. The Journal of Pharmacology and Experimental Therapeutics.

Guida et al. (2012). Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection. Molecular Pain.

Harden et al. (2012). Antidepressive effects of the κ-opioid receptor agonist salvinorin A in a rat model of anhedonia. Behavioural Pharmacology.

Lovell et al. (2012). Semisynthetic neoclerodanes as kappa opioid receptor probes. Bioorganic & Medicinal Chemistry.

Meyer & Writer (2012). Salvia divinorum. Psychosomatics.

Perron et al. (2012). Use of Salvia divinorum in a nationally representative sample. The American Journal of Drug and Alcohol Abuse.

Piekielna, Fichna & Janecka (2012). [Salvinorin A and related diterpenes--biological activity and potential therapeutic uses]. Postepy Biochemii.

Ranganathan et al. (2012). Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans. Biological Psychiatry.

Stogner et al. (2012). Regulating a novel drug: an evaluation of changes in use of Salvia divinorum in the first year of Florida's ban. The International Journal on Drug Policy.

Travis, Ray & Marlowe (2012). A report of nausea and vomiting with discontinuation of chronic use of salvia divinorum. Case Reports in Medicine.

Willard, McGuffin & Smith (2012). Forensic analysis of Salvia divinorum using multivariate statistical procedures. Part I: discrimination from related Salvia species. Analytical and Bioanalytical Chemistry.

Willard, McGuffin & Smith (2012). Forensic analysis of Salvia divinorum using multivariate statistical procedures. Part II: association of adulterated samples to S. divinorum. Analytical and Bioanalytical Chemistry.

Currie (2013). Epidemiology of adolescent Salvia divinorum use in Canada. Drug and Alcohol Dependence.

Diaz (2013). Salvia divinorum: a psychopharmacological riddle and a mind-body prospect. Current Drug Abuse Reviews

Dueweke (2013). Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: what are the clinical features of Salvia divinorum toxicity? Emergency Medicine Journal.

Kowalczuk et al. (2013). Vegetative anatomy and micromorphology of Salvia divinorum (Lamiaceae) from Mexico, combined with chromatographic analysis of salvinorin A. Journal of Natural Medicines.

MacLean et al. (2013). Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology.

Miller, Boman & Stogner (2013). Examining the measurement of novel drug perceptions: Salvia divinorum, gender, and peer substance use. Substance Use & Misuse.

Murphy & Bola (2013). DNA identification of Salvia divinorum samples. Forensic Science International: Genetics.

Paudel et al. (2013). Development of an enzyme immunoassay using a monoclonal antibody against the psychoactive diterpenoid salvinorin A. Journal of Natural Products.

Polepally et al. (2013). Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands. Bioorganic & Medicinal Chemistry Letters.

Prisinzano (2013). Neoclerodanes as atypical opioid receptor ligands. Journal of Medicinal Chemistry.

Riley et al. (2013). Palladium-catalyzed transformations of salvinorin A, a neoclerodane diterpene from Salvia divinorum. Organic Letters.

Sanders, Stogner & Miller (2013).  Perception vs. reality: an investigation of the misperceptions concerning the extent of peer novel drug use. Journal of Drug Education.

Zawilska & Wojcieszak (2013). Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug. Human Psychopharmacology.

Casselman et al. (2014). From local to global-fifty years of research on Salvia divinorum. Journal of Ethnopharmacology.

dos Santos et al. (2014). Salvinorin a and related compounds as therapeutic drugs for psychostimulant-related disorders. Current Drug Abuse Reviews.

Gutierrez & Cooper (2014). Investigating correlates of synthetic marijuana and Salvia use in light and intermittent smokers and college students in a predominantly Hispanic sample. Experimental and Clinical Psychopharmacology.

Hamidpour et al. (2014). Chemistry, pharmacology, and medicinal property of sage (salvia) to prevent and cure illnesses such as obesity, diabetes, depression, dementia, lupus, autism, heart disease, and cancer. Journal of Traditional and Complementary Medicine.

Kivell, Ewald & Prisinzano (2014). Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse. Advances in Pharmacology.

Krstenansky & Muzzio (2014). Analysis of the smoke of cigarettes containing Salvia divinorum. Journal of Analytical Toxicology.

Lin et al. (2014). Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan. Journal of Food and Drug Analysis.

Polepally et al. (2014). Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor. European Journal of Medicinal Chemistry.

Riley et al. (2014). Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues. Journal of Medicinal Chemistry.

Stiefel, Merrifield & Holcombe (2014). The claustrum's proposed role in consciousness is supported by the effect and target localization of Salvia divinorum. Frontiers in Integrative Neuroscience.

Sufka et al. (2014). The effect of Salvia divinorum and Mitragyna speciosa extracts, fraction and major constituents on place aversion and place preference in rats. Journal of Ethnopharmacology.

Winslow & Mahendran (2014). From divination to madness: features of acute intoxication with Salvia use. Singapore Medical Journal.

Xavier et al. (2014). Analytical investigation of legal high products containing Salvia divinorum traded in smartshops and internet. Forensic Science International.

Sami (2015). Psychosis, psychedelic substance misuse and head injury: A case report and 23 year follow-up. Brain Injury.